References
- Brodie B. B., Bickel M. H., Sulser F. Med. exp. 1961; 5: 454
- Bruun I. Klinisk gennemprövning af Imipramin-N-oxyd. Nyt antidepressivum. Nord. psykiat. T. 1968, In press
- Fishman V., Goldenberg H. Proc. Soc. exp. Biol. Med. 1962; 110: 187
- Faurbye A., Jacobsen O., Kristjansen P., Munkvad I. Amer. J. of Psychiatr. 1963; 120: 277
- Faurbye A., Jacobsen O., Kristjansen P., Munkvad I. Etude preliminaire de l'action antidepressive de l'imipramine-N-oxyde. Comp-tesrendus de congrès de psychiatrie et de neurologic. 1963, Extrait des Nancy. 371
- Gottfries C. G., Gottjries I., Olsson E. Brit. J. Psychiat. 1966; 112: 1269
- Haug O. Klinisk utprövning av det nye antidepressive medikament imipratnin-N-oxyd. Nord. psychiat. T. 1967; 21: 145
- Hansen T. Absorption, distribution, elimination and metabolism of Imipramine-N-oxide. Experiments on rabbits, rats and man, To be published
- Herrmann B., Pulver R. Arch. int. pharmacodyn. 1960; CXXVI(3–4)454
- Herrmann B., Schindler W., Pulver R. Med. exp. 1959; 1: 381
- Kristjansen P., Larsen V. Den relative cardiologiske toxicitet af imipramine-N-oxide. (Imiprex®). Ugeskr. Læg. 1967; 129: 1297
- Larsen V. Acta pharmacol. et toxicol. 1963; 20: 186
- Larsen V. Some pharmacological and toxicological properties of Imipramine-N-oxide, To be published